Page 1695 - Clinical Small Animal Internal Medicine
P. 1695

Index  1633

               salmon poisoning disease (SPD)      bone and joint tumors  1329     seminomas  1311–1312
  VetBooks.ir    diagnosis  914                    gastrointestinal imaging  472–473  SENL see surgically assisted endoscopic
                                                                                   senile osteoporosis  1527
                   913–915
                                                   cirrhosis  708
                                                                                      nephrolithotomy
                                                   hepatobiliary disease  659, 674
                 epidemiology  913
                 etiology/pathophysiology  913, 914  motility disorders  568–569   sensory neuropathies  1488
                 history and clinical signs  913–914  portosystemic shunts and     sentinel acute pancreatitis event (SAPE)
                 prognosis  914                      microvascular dysplasia          hypothesis  592
                 public health implications  914     716, 719                      sentinel lymph node (SNL)  1210
                 signalment  913                 screening tests  10, 1385–1394    sepsis/septic shock  421–429
                 treatment  914                  scrotal tumors  1313–1314           antimicrobial therapy  427–428
               SAM see systolic anterior motion of the   SD see sudden death         diagnosis  425–426
                   mitral valve                  sebaceous adenitis (SA)  1495–1498  dysregulated immunity  422
               sampling and sample size  7, 10, 24  diagnosis  1496–1497             epidemiology  424
               SAPE see sentinel acute pancreatitis   etiology/pathophysiology  1495  etiology/pathophysiology
                   event                           history and clinical signs         421–424, 422
               saprophytic mycobacteriosis  980–984  1495–1496, 1496                 feline inflammatory liver disease  690
               sarcomas                            prognosis  1498                   history and clinical signs
                 hepatobiliary tumors  1304, 1306  signalment  1495                   424–425
                 mammary cancer  1323              treatment  1497–1498              hypoglycemia  108
                 orbital and optic nerve tumors  1267  sebaceous benign tumors  1354  innate immunity  421–422
                 soft tissue sarcomas  1333–1338  secondary orbital tumors  1269     motility disorders  571–572
               sarcoplasmic reticulum  175–176, 182  secondary uveal neoplasms  1267  physiologic consequences
               SARS see severe acute respiratory   sedation                           422–424
                   syndrome                        heart failure  197                prognosis  428
               SAS see subaortic stenosis          rectoanal diseases  616           response to infection or injury
               SBA see serum bile acid             respiratory pattern‐based approach   421–424
               scabies  1454–1456                    to dyspnea  290–291             resuscitation  426–427
                 canine  1454–1455                 spinal cord injury  743           signalment  424
                 diagnosis  1455–1456              surgical, traumatic, and bite wound   source control  427
                 etiology/pathophysiology  1454,     infections  1031, 1034          supportive care  428
                   1454, 1456                      trauma and burns  451–452         trauma and burns  454
                 feline  1456                    seizures/epilepsy  759–766          treatment  426–428
                 history and clinical signs        axis 1: seizure phenomenology     septal defects  151, 160
                   1454–1456, 1455–1456              759–760                       septal flattening  229
                 treatment and prognosis           axis 2: seizure type  761       serology see blood chemistry/serology
                   1455–1456                       axis 3: etiology  761           serotonergic 5‐HT 4  agonists
               scales                              axis 4: syndrome  761              575, 579
                 approach to the dermatologic      axis 5: impairment from         serotonin receptor agonists  302
                   patient  1386                     epilepsy  761                 Sertoli cell tumors  1311
                 autoimmune and immune‐mediated    cardiogenic shock  415          Sertoli‐Leydig cell tumors  1319
                   skin disease  1426              diagnosis  762                  serum albumin concentration
                 miscellaneous skin diseases  1496,   head trauma  756–757            630–632
                   1500–1503, 1501–1502            history and clinical signs      serum bile acid (SBA)  652
               scatterplots  12, 13                  759–761, 760                  serum cobalamin concentration  632
               SCC see squamous cell carcinoma     hyperthermia  434               serum protein electrophoresis
               SCFE see slipped capital femoral    meningoencephalitis and            (SPE)  1243–1244, 1243
                   epiphysis                         meningomyelitis  801          severe acidemia  1178
               Schiff–Sherrington posture  818     pathophysiology  759, 760       severe acute respiratory syndrome
               schistocytes  1219                  portosystemic shunts and           (SARS)  4–5, 1037–1038
               schistocytosis  317                   microvascular dysplasia  718  severe fibrosing pleuritis  343
               Schmidt syndrome  113–114           treatment  762–766, 767         severe pulmonic stenosis  138
               SCI see spinal cord injury          see also movement disorders     sex hormone dermatoses  1483
               scintigraphy                      selection bias  23–24             SGPS see sterile granuloma/
                 biology of cancer and cancer    selective pulmonary angiography      pyogranuloma syndrome
                   genetics  1210                    319–320                       SH see systemic histiocytosis
   1690   1691   1692   1693   1694   1695   1696   1697   1698   1699   1700